NeoGenomics
Runs cancer diagnostic laboratories serving community oncologists, pathologists, and pharmaceutical trial sponsors.
$18.20
After-hours close+0.15 (+0.86%)
At close$18.05(−3.19%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 576.74%Insiders 4.76%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 25.70M · Float 23.31M · 90.7% free float
Institutions13F, as of Jun 30, 2026
277 holders · 148.19M shares · 61 new positions · 159 increased · 62 reduced · 45 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 20.87M | 81.22% | +910.9K | Aug 7, 2026 |
| First Light Asset Management, LLC | 12.28M | 47.79% | +2.55M | Aug 14, 2026 |
| First Trust Advisors LP | 10.11M | 39.36% | +3.95M | Aug 11, 2026 |
| Greenhouse Funds LLLP | 8.57M | 33.37% | −525.9K | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 8.06M | 31.37% | +439.2K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 5.76M | 22.43% | +107.2K | Aug 13, 2026 |
| State Street Corp | 5.36M | 20.87% | +243.9K | Aug 7, 2026 |
| Macquarie Management Holdings, Inc. | 5.04M | 19.61% | +1.59M | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 14.60% | 18.86M | 13G | Oct 17, 2025 ↗ |
| First Light Asset Management, LLC | 10.47% | 13.63M | 13G | May 7, 2026 ↗ |
| First Trust Portfolios L.P. | 7.77% | 10.11M | 13G | Jul 30, 2026 ↗ |
| Greenhouse Funds LLLP | 7.10% | 9.22M | 13G | May 15, 2026 ↗ |
| Vanguard Portfolio Management | 5.91% | 7.68M | 13G | Apr 29, 2026 ↗ |
| Vanguard Capital Management | 5.09% | 6.61M | 13G | Apr 30, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Jeffrey Scott Sherman | officer: Chief Financial Officer | 220.0K | 0.86% | Feb 24, 2026 |
| Warren Stone | officer: Pres & Chief Operating Officer | 181.1K | 0.70% | Aug 25, 2026 |
| Anthony P. Zook | director, officer: Chief Executive Officer | 152.0K | 0.59% | Apr 3, 2026 |
| Alison L. Hannah | director | 131.0K | 0.51% | Jun 3, 2025 |
| Alicia C. Olivo | officer: EVP, GC & Business Development | 93.6K | 0.36% | May 13, 2026 |
| Lynn A. Tetrault | director | 93.1K | 0.36% | Jun 17, 2026 |
| Stephen M. Kanovsky | director | 75.4K | 0.29% | Jun 3, 2026 |
| Michael Aaron Kelly | director | 72.1K | 0.28% | Jun 3, 2026 |
| David Brian Perez | director | 67.0K | 0.26% | Jun 3, 2026 |
| Neil Gunn | director | 51.2K | 0.20% | Jun 3, 2026 |
1 ten-percent owner holds 4.85M shares by Form 4, outside the officers-and-directors figure above · 33 people have not refiled in the last 18 months (7.11M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 4, 2026 | Greg D. Aunanofficer: Chief Accounting Officer | Sale | 20,000 | $16.07 | 5,153 |
| Jun 15, 2026 | Lynn A. Tetraultdirector | Sale | 5,307 | $11.10 | 86,115 |
| Jun 9, 2026 | Lynn A. Tetraultdirector | Sale | 5,307 | $11.29 | 91,422 |
| Jan 20, 2026 | Warren Stoneofficer: Pres & Chief Operating Officer | Sale | 22,128 | $12.50 | 121,631 |
| Nov 25, 2025 | Alicia C. Olivoofficer: EVP, GC & Business Development | Sale | 20,916 | $12.00 | 31,083 |
CongressHouse and Senate disclosures
Not reported.